REQUEST A DEMO
Total
USD $0.00
Search more companies

Darou Pakhsh Pharma Chemicals Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Darou Pakhsh Pharma Chemicals Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Darou Pakhsh Pharma Chem Co. (DPPC) is an Iranian company producing active pharmaceutical ingredients. It was founded in 1993 and became operational in 1997. Part of its production is exported to countries in Europe, Latin America, Middle East and CIS. Darou Pakhsh has a plant in the town of Kermanshah producing veterinary products for the local market and for exports.

Headquarters
Kilometer 18 Of The Tehran-Karaj Highway, Darou Pakhsh Ave, Taleghani St
Karaj; Alborz;

Contact Details: Purchase the Darou Pakhsh Pharma Chemicals Company Public Joint Stock report to view the information.

Website: http://www.dppcco.com

Basic Information
Total Employees:
Purchase the Darou Pakhsh Pharma Chemicals Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Darou Pakhsh Pharma Chemicals Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Darou Pakhsh Pharma Chemicals Company Public Joint Stock report to view the information.
Incorporation Date:
1997
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
75.98%
Purchase this report to view the information.
Subsidiaries
Darou Pakhsh Factories
Company Performance
Financial values in the chart are available after Darou Pakhsh Pharma Chemicals Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
82.32%
Total operating revenue
82.05%
Operating profit (EBIT)
66%
EBITDA
59.93%
Net Profit (Loss) for the Period
90.13%
Total assets
46.68%
Total equity
63.17%
Operating Profit Margin (ROS)
-3.7%
Net Profit Margin
1.25%
Return on Equity (ROE)
10.67%
Debt to Equity Ratio
-24.66%
Quick Ratio
0.47%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?